SLC26A3 and colonic neoplasm: SLC26A3 was shown to be primarily expressed in colon cancer, but its expression is significantly decreased in colon cancer and colon cancer cell lines, and the down‐regulated expression of SLC26A3 was shown to be associated with the progression of colon cancer.8